SGLT2is: The New Pillar in Heart Failure Care

What You Will Learn

  • Identify clinical indications and key considerations for selection of SGLT2 inhibitors

  • Establish a contemporary prescribing timeline for SGLT2 inhibitors

  • Practical considerations of SGLT2is including initiation, dosing, and monitoring

  • Overcome barriers to SGLT2i initiation
Meeting On Demand

An educational activity that has been recorded for viewing

We are grateful to these distinguished Members of the American College of Cardiology who contributed to this collection:

 

Alison L. Bailey, MD, FACC

 

James L. Januzzi, Jr., MD, FACC

 

Nosheen Reza, MD, FACC

 

Shashank S. Sinha, MD, FACC

 

Muthiah Vaduganathan, MD, FACC

 

 

Supported by an independent educational grant from: AstraZeneca and Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company | Page Launched: April 2022

Android App Download IOS App Download Powered By